South Africa Becomes a Key Player in Astrazeneca’s Global Clinical Trial Success

Nairobi — South Africa has emerged as a crucial country for clinical trials in AstraZeneca’s global operations, playing a pivotal role in advancing medical research and delivering innovative treatments.

Through groundbreaking efforts in respiratory, cardiovascular, and oncology research, AstraZeneca’s clinical trials in South Africa are revolutionising patient care at the local level while making a meaningful contribution to the global health landscape.

Over recent years, South Africa has seen a…